Free Trial

Polarean Imaging (POLX) Competitors

Polarean Imaging logo
GBX 1.38 -0.02 (-1.64%)
As of 07/3/2025 06:15 AM Eastern

POLX vs. CREO, IUG, NCYT, IHC, AVO, RUA, SUN, MHC, BELL, and DEMG

Should you be buying Polarean Imaging stock or one of its competitors? The main competitors of Polarean Imaging include Creo Medical Group (CREO), Intelligent Ultrasound Group (IUG), Novacyt (NCYT), Inspiration Healthcare Group (IHC), Advanced Oncotherapy (AVO), RUA Life Sciences (RUA), Surgical Innovations Group (SUN), MyHealthChecked (MHC), Belluscura (BELL), and Deltex Medical Group (DEMG). These companies are all part of the "medical devices" industry.

Polarean Imaging vs. Its Competitors

Polarean Imaging (LON:POLX) and Creo Medical Group (LON:CREO) are both small-cap medical companies, but which is the better investment? We will compare the two businesses based on the strength of their media sentiment, institutional ownership, profitability, analyst recommendations, dividends, valuation, earnings and risk.

Polarean Imaging has a beta of 0.38, indicating that its share price is 62% less volatile than the S&P 500. Comparatively, Creo Medical Group has a beta of 0.86, indicating that its share price is 14% less volatile than the S&P 500.

Creo Medical Group has higher revenue and earnings than Polarean Imaging. Creo Medical Group is trading at a lower price-to-earnings ratio than Polarean Imaging, indicating that it is currently the more affordable of the two stocks.

CompanyGross RevenuePrice/Sales RatioNet IncomeEarnings Per SharePrice/Earnings Ratio
Polarean Imaging£5.21M3.88-£69.44M-£3.89-0.35
Creo Medical Group£33.87M1.52-£25.04M-£6.32-2.02

12.1% of Polarean Imaging shares are owned by institutional investors. Comparatively, 56.1% of Creo Medical Group shares are owned by institutional investors. 39.3% of Polarean Imaging shares are owned by insiders. Comparatively, 22.4% of Creo Medical Group shares are owned by insiders. Strong institutional ownership is an indication that endowments, hedge funds and large money managers believe a company is poised for long-term growth.

Creo Medical Group has a net margin of -73.93% compared to Polarean Imaging's net margin of -1,333.97%. Creo Medical Group's return on equity of -41.79% beat Polarean Imaging's return on equity.

Company Net Margins Return on Equity Return on Assets
Polarean Imaging-1,333.97% -86.11% -32.28%
Creo Medical Group -73.93%-41.79%-20.09%

In the previous week, Polarean Imaging's average media sentiment score of 0.00 equaled Creo Medical Group'saverage media sentiment score.

Company Overall Sentiment
Polarean Imaging Neutral
Creo Medical Group Neutral

Summary

Creo Medical Group beats Polarean Imaging on 7 of the 11 factors compared between the two stocks.

Get Polarean Imaging News Delivered to You Automatically

Sign up to receive the latest news and ratings for POLX and its competitors with MarketBeat's FREE daily newsletter.

New MarketBeat Followers Over Time

This chart shows the number of new MarketBeat users adding POLX and its top 5 competitors to their watchlist. Each company is represented with a line over a 90 day period.
Skip Chart

Media Sentiment Over Time

This chart shows the average media sentiment of LON and its competitors over the past 90 days as caculated by MarketBeat. The averaged score is equivalent to the following: Very Negative Sentiment <= -1.5, Negative Sentiment > -1.5 and <= -0.5, Neutral Sentiment > -0.5 and < 0.5, Positive Sentiment >= 0.5 and < 1.5, and Very Positive Sentiment >= 1.5.
Skip Chart

POLX vs. The Competition

MetricPolarean ImagingMedical Devices IndustryMedical SectorLON Exchange
Market Cap£20.21M£3.41B£5.53B£2.96B
Dividend YieldN/A2.44%5.24%5.02%
P/E Ratio-0.3572.9727.52146.59
Price / Sales3.88103.14421.02240,167.53
Price / Cash4.9315.9936.8927.97
Price / Book0.423.858.045.30
Net Income-£69.44M£132.05M£3.18B£5.90B
7 Day Performance0.36%11.83%2.90%0.97%
1 Month Performance0.88%8.05%3.70%5.00%
1 Year Performance-15.26%12.81%36.15%81.47%

Polarean Imaging Competitors List

CompanyMarketRankShare PriceAnalysts' Price Target1Y Price PerformanceMarket CapRevenueP/E RatioEmployee CountIndicator(s)
POLX
Polarean Imaging
N/AGBX 1.38
-1.6%
N/A-19.0%£20.21M£5.21M-0.3528Gap Up
CREO
Creo Medical Group
N/AGBX 13.64
+1.0%
N/A-61.7%£55.12M£33.87M-2.16279
IUG
Intelligent Ultrasound Group
N/AN/AN/AN/A£42.76M£6.57M-18.9165
NCYT
Novacyt
N/AGBX 42.30
+3.2%
N/A-15.3%£29.23M£18.12M-0.78120Positive News
IHC
Inspiration Healthcare Group
N/AGBX 23.05
-1.9%
N/A+26.9%£19.97M£42.87M-1.58224
AVO
Advanced Oncotherapy
N/AN/AN/AN/A£9.50MN/A-25.003,900Gap Down
RUA
RUA Life Sciences
N/AGBX 12.50
-6.5%
N/A+12.3%£7.76M£4.05M-2.9148Gap Down
High Trading Volume
SUN
Surgical Innovations Group
N/AGBX 0.65
-7.0%
N/A+51.1%£6.07M£12.54M-21.1180Gap Up
High Trading Volume
MHC
MyHealthChecked
N/AGBX 11.40
+6.0%
N/A+5.3%£5.93M£9.43M-5.6916Earnings Report
Gap Up
BELL
Belluscura
N/AGBX 0.74
+1.8%
N/AN/A£1.86M£2.87M-0.0824
DEMG
Deltex Medical Group
N/AN/AN/AN/A£187K£1.76M-0.1537Gap Up
High Trading Volume

Related Companies and Tools


This page (LON:POLX) was last updated on 7/5/2025 by MarketBeat.com Staff
From Our Partners